Young Eun Choi

Title: Young Eun Choi: Innovator in DNA Polymerase Theta Inhibition

Introduction

Young Eun Choi is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target DNA polymerase theta. His work is crucial for advancing treatments for various cancers.

Latest Patents

Young Eun Choi holds a patent for "Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof." This patent discloses compounds that inhibit DNA Polymerase Theta (Polθ) activity, specifically by targeting the ATP-dependent helicase domain activity of Polθ. The patent also includes pharmaceutical compositions that utilize these compounds and outlines methods for treating diseases that can be addressed through Polθ inhibition, such as homologous recombination (HR) deficient cancers.

Career Highlights

Throughout his career, Young Eun Choi has worked with prominent companies in the biotechnology sector. He has been associated with Ideaya Biosciences, Inc. and GlaxoSmithKline Intellectual Property (No.2) Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Young Eun Choi has collaborated with several professionals in his field, including Janos Botyanszki and Claire L Neilan. These collaborations have likely enhanced his research and development efforts.

Conclusion

Young Eun Choi is a distinguished inventor whose work on DNA polymerase theta inhibitors holds promise for cancer treatment. His contributions to the field are invaluable and reflect his commitment to advancing medical science.